|
Status |
Public on Sep 24, 2020 |
Title |
AG663510-4 |
Sample type |
SRA |
|
|
Source name |
Melanoma
|
Organism |
Homo sapiens |
Characteristics |
sample type: Tumor Biopsy individual: 2000116102 cohort: SCREEN FAIL visit: SCREENING site description: METASTATIC SITE site: LYMPH NODE treatment: durva.mek braf mutation: Braf.wt
|
Extracted molecule |
total RNA |
Extraction protocol |
Qiagen Takara Bio SMART-Seq: SMART-Seq v4 Ultra Low Input RNA Kit RNA sequening was performed on Illumina HiSeq 2500 with 2x75 bp reads.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Description |
polyA RNA
|
Data processing |
RNAseq reads were aligned using HISAT2 to the human reference genome GRCh38. FPKM values were generated using Stringtie. Genome_build: GRCh38 Supplementary_files_format_and_content: tab-delimited text file includes FPKM values for each sample
|
|
|
Submission date |
Sep 23, 2020 |
Last update date |
Sep 24, 2020 |
Contact name |
Antoni Ribas |
E-mail(s) |
aribas@mednet.ucla.edu
|
Phone |
(310) 206-3928
|
Organization name |
University of California, Los Angeles
|
Department |
Medicine, HemOnc Division
|
Street address |
9-954 Factor Bldg
|
City |
Los Angeles |
State/province |
CA |
ZIP/Postal code |
90095-1678 |
Country |
USA |
|
|
Platform ID |
GPL16791 |
Series (1) |
GSE158403 |
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma |
|
Relations |
BioSample |
SAMN16244649 |
SRA |
SRX9176468 |